These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 6143285
1. Biochemistry of the hypothalamus in Parkinson's disease. Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y. Neurology; 1984 May; 34(5):672-5. PubMed ID: 6143285 [Abstract] [Full Text] [Related]
6. Brain amine concentrations after monoamine oxidase inhibitor administration. Jones AB, Pare CM, Nicholson WJ, Price K, Stacey RS. Br Med J; 1972 Jan 01; 1(5791):17-9. PubMed ID: 5008339 [Abstract] [Full Text] [Related]
7. Mechanisms of Parkinson's disease. Br Med J; 1978 Apr 08; 1(6117):872-3. PubMed ID: 25109 [No Abstract] [Full Text] [Related]
8. Neurotransmitter levels in the hypothalamus during postnatal development of rats. Macho L, Kvetnanský R, Culman J, Ficková M. Exp Clin Endocrinol; 1986 Dec 08; 88(2):142-50. PubMed ID: 2881796 [Abstract] [Full Text] [Related]
9. [Progresses in the study of unbalance of basal ganglia neurotransmitters in Parkinson's disease]. Sun ZL, Jia J, Yu F. Sheng Li Ke Xue Jin Zhan; 2011 Dec 08; 42(6):427-30. PubMed ID: 22363981 [No Abstract] [Full Text] [Related]
10. Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission. Vécsei L, Kovács GL, Faludi M, Bollók I, Telegdy G. Acta Physiol Hung; 1985 Dec 08; 66(2):213-7. PubMed ID: 2864776 [Abstract] [Full Text] [Related]
11. Brain neurotransmitters and neuropeptides in Parkinson's disease. Rinne UK, Rinne JO, Rinne JK, Laakso K, Lönnberg P. Acta Physiol Pharmacol Latinoam; 1984 Dec 08; 34(3):287-99. PubMed ID: 6099688 [Abstract] [Full Text] [Related]
12. Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. Hökfelt T, Elde R, Fuxe K, Johansson O, Ljungdahl A, Goldstein M, Luft R, Efendic S, Nilsson G, Terenius L, Ganten D, Jeffcoate SL, Rehfeld J, Said S, Perez de la Mora M, Possani L, Tapia R, Teran L, Palacios R. Res Publ Assoc Res Nerv Ment Dis; 1978 Dec 08; 56():69-135. PubMed ID: 23576 [No Abstract] [Full Text] [Related]
13. Aging effects on hypothalamic dopamine and norepinephrine content in the male rat. Miller AE, Shaar CJ, Riegle GD. Exp Aging Res; 1976 Sep 08; 2(5):475-80. PubMed ID: 1017462 [Abstract] [Full Text] [Related]
14. Orexigenic effects of endomorphin-2 (EM-2) related to decreased CRH gene expression and increased dopamine and norepinephrine activity in the hypothalamus. Brunetti L, Ferrante C, Orlando G, Recinella L, Leone S, Chiavaroli A, Di Nisio C, Shohreh R, Manippa F, Ricciuti A, Mollica A, Vacca M. Peptides; 2013 Oct 08; 48():83-8. PubMed ID: 23916912 [Abstract] [Full Text] [Related]
16. Neurotransmitters and hypothalamic hormones in the central nervous system. Brownstein M. Fed Proc; 1977 Jun 08; 36(7):1960-3. PubMed ID: 16784 [No Abstract] [Full Text] [Related]
17. [Effect of monoamine neurotransmitters in the hypothalamus in a cortisol-induced rat model of yang-deficiency]. Chen M, Kuang A, Chen J. Zhong Xi Yi Jie He Za Zhi; 1990 May 08; 10(5):292-4, 262. PubMed ID: 1975774 [Abstract] [Full Text] [Related]
18. The biochemistry of the basal ganglia and Parkinson's disease. Curzon G. Postgrad Med J; 1977 Dec 08; 53(626):719-25. PubMed ID: 24209 [Abstract] [Full Text] [Related]